Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR vs 3-Day Azithromycin for Strep Pharyngitis/Tonsillitis
NCT00644293Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in streptococcal pharyngitis and tonsillitis (2 arms), sponsored by Pfizer. Primary endpoint: Bacteriologic Response in the Bacteriologic per Protocol Population. Started Jan 2003; status: completed.
02
Drugs
azithromycin
03
Conditions
streptococcal pharyngitistonsillitis
Beyond the preview
Go deeper on NCT00644293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644293.